rs147465559

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020376.4(PNPLA2):​c.1237G>A​(p.Ala413Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000435 in 1,581,082 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00026 ( 2 hom. )

Consequence

PNPLA2
NM_020376.4 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.146

Publications

0 publications found
Variant links:
Genes affected
PNPLA2 (HGNC:30802): (patatin like phospholipase domain containing 2) This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]
PNPLA2 Gene-Disease associations (from GenCC):
  • neutral lipid storage myopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003961593).
BP6
Variant 11-824584-G-A is Benign according to our data. Variant chr11-824584-G-A is described in ClinVar as Benign. ClinVar VariationId is 465781.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00206 (314/152232) while in subpopulation AFR AF = 0.00686 (285/41546). AF 95% confidence interval is 0.00621. There are 2 homozygotes in GnomAd4. There are 156 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PNPLA2NM_020376.4 linkc.1237G>A p.Ala413Thr missense_variant Exon 10 of 10 ENST00000336615.9 NP_065109.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PNPLA2ENST00000336615.9 linkc.1237G>A p.Ala413Thr missense_variant Exon 10 of 10 1 NM_020376.4 ENSP00000337701.4

Frequencies

GnomAD3 genomes
AF:
0.00202
AC:
308
AN:
152124
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00673
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000651
AC:
124
AN:
190432
AF XY:
0.000541
show subpopulations
Gnomad AFR exome
AF:
0.00703
Gnomad AMR exome
AF:
0.000466
Gnomad ASJ exome
AF:
0.00260
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000728
Gnomad OTH exome
AF:
0.000400
GnomAD4 exome
AF:
0.000261
AC:
373
AN:
1428850
Hom.:
2
Cov.:
43
AF XY:
0.000226
AC XY:
160
AN XY:
709146
show subpopulations
African (AFR)
AF:
0.00734
AC:
243
AN:
33092
American (AMR)
AF:
0.000462
AC:
19
AN:
41094
Ashkenazi Jewish (ASJ)
AF:
0.00195
AC:
50
AN:
25586
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38452
South Asian (SAS)
AF:
0.0000723
AC:
6
AN:
82978
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42192
Middle Eastern (MID)
AF:
0.000179
AC:
1
AN:
5574
European-Non Finnish (NFE)
AF:
0.0000164
AC:
18
AN:
1100574
Other (OTH)
AF:
0.000607
AC:
36
AN:
59308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00206
AC:
314
AN:
152232
Hom.:
2
Cov.:
33
AF XY:
0.00210
AC XY:
156
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00686
AC:
285
AN:
41546
American (AMR)
AF:
0.000849
AC:
13
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67974
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000636
Hom.:
0
Bravo
AF:
0.00224
ESP6500AA
AF:
0.00529
AC:
23
ESP6500EA
AF:
0.000118
AC:
1
ExAC
AF:
0.000633
AC:
75
Asia WGS
AF:
0.000579
AC:
2
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neutral lipid storage myopathy Benign:2
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.65
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.15
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.49
N
REVEL
Benign
0.074
Sift
Uncertain
0.018
D
Sift4G
Uncertain
0.058
T
Polyphen
1.0
D
Vest4
0.037
MVP
0.46
MPC
0.27
ClinPred
0.0099
T
GERP RS
2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.029
gMVP
0.31
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147465559; hg19: chr11-824584; COSMIC: COSV107407417; COSMIC: COSV107407417; API